Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H13N3 |
| Molecular Weight | 199.2517 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=CC=C(NC2=CC=C(N)C=C2)C=C1
InChI
InChIKey=QZHXKQKKEBXYRG-UHFFFAOYSA-N
InChI=1S/C12H13N3/c13-9-1-5-11(6-2-9)15-12-7-3-10(14)4-8-12/h1-8,15H,13-14H2
| Molecular Formula | C12H13N3 |
| Molecular Weight | 199.2517 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity. | 2006-06-15 |
|
| Excited state solvatochromic and prototropic behaviour of 4-aminodiphenylamine and 4,4'-diaminodiphenylamine--a comparative study by electronic spectra. | 2006-06 |
|
| Control of hepatitis C: a medicinal chemistry perspective. | 2005-01-13 |
|
| Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules. | 2000-06-05 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:30:06 GMT 2025
by
admin
on
Mon Mar 31 19:30:06 GMT 2025
|
| Record UNII |
R24HL8M2C7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID1060217
Created by
admin on Mon Mar 31 19:30:06 GMT 2025 , Edited by admin on Mon Mar 31 19:30:06 GMT 2025
|
PRIMARY | |||
|
R24HL8M2C7
Created by
admin on Mon Mar 31 19:30:06 GMT 2025 , Edited by admin on Mon Mar 31 19:30:06 GMT 2025
|
PRIMARY | |||
|
m4251
Created by
admin on Mon Mar 31 19:30:06 GMT 2025 , Edited by admin on Mon Mar 31 19:30:06 GMT 2025
|
PRIMARY | Merck Index | ||
|
208-673-4
Created by
admin on Mon Mar 31 19:30:06 GMT 2025 , Edited by admin on Mon Mar 31 19:30:06 GMT 2025
|
PRIMARY | |||
|
537-65-5
Created by
admin on Mon Mar 31 19:30:06 GMT 2025 , Edited by admin on Mon Mar 31 19:30:06 GMT 2025
|
PRIMARY | |||
|
10841
Created by
admin on Mon Mar 31 19:30:06 GMT 2025 , Edited by admin on Mon Mar 31 19:30:06 GMT 2025
|
PRIMARY | |||
|
33417
Created by
admin on Mon Mar 31 19:30:06 GMT 2025 , Edited by admin on Mon Mar 31 19:30:06 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |